» Articles » PMID: 39962376

Comparative Metabolomics Reveals Streptophenazines with Anti-methicillin-resistant Staphylococcus Aureus Activity Derived from Streptomyces Albovinaceus Strain WA10-1-8 Isolated from Periplaneta Americana

Overview
Journal BMC Microbiol
Publisher Biomed Central
Specialty Microbiology
Date 2025 Feb 18
PMID 39962376
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Streptophenazines, a class of phenazine compounds with a variety of alkyl side chains and activity against methicillin-resistant Staphylococcus aureus (MRSA), are mainly derived from soil or marine microbial secondary metabolites. However, the discovered phenazine compounds still do not meet the needs of the development of anti-MRSA lead compounds. Here, we examined secondary metabolites of Streptomyces albovinaceus WA10-1-8 isolated from Periplaneta americana, for streptophenazines with anti-MRSA activity.

Results: In this study, a guidance method combining high-performance liquid chromatography-ultraviolet (HPLC-UV) with molecular networking analysis was used to isolate and identify a series of streptophenazines (A-T) from S. albovinaceus WA10-1-8. Among them, a new streptophenazine containing a dihydroxyalkyl chain structure named streptophenazine T was isolated and identified for the first time. The results of bioactivity assays showed that streptophenazine T had anti-MRSA activity with a minimum inhibitory concentration (MIC) of 150.23 µM, while the MICs of streptophenazine A, B, G, and F were 37.74-146.12 µM.

Conclusions: This study was the first to report multiple streptophenazine compounds with anti-MRSA activity expressed by Streptomyces isolated from insect niches. These results provided a valuable reference for future exploration of new streptophenazine compounds with activity against drug-resistant bacteria.

References
1.
Ma Y, Guo P, Chen X, Xu M, Liu W, Jin X . Anti-Klebsiella pneumoniae activity of secondary metabolism of Achromobacter from the intestine of Periplaneta americana. BMC Microbiol. 2023; 23(1):162. PMC: 10240788. DOI: 10.1186/s12866-023-02909-7. View

2.
Ko H, Lareu R, Dix B, Hughes J . In vitro antibacterial effects of statins against bacterial pathogens causing skin infections. Eur J Clin Microbiol Infect Dis. 2018; 37(6):1125-1135. DOI: 10.1007/s10096-018-3227-5. View

3.
Huang H, Zhou J, Nie X, Yi Q . [Analysis of the relationship between the MecA gene and resistance of β-lactam antibiotics]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012; 37(6):567-71. DOI: 10.3969/j.issn.1672-7347.2012.06.005. View

4.
Lee N, Hwang S, Lee Y, Cho S, Palsson B, Cho B . Synthetic Biology Tools for Novel Secondary Metabolite Discovery in . J Microbiol Biotechnol. 2019; 29(5):667-686. DOI: 10.4014/jmb.1904.04015. View

5.
Jaradat Z, Ababneh Q, Shaaban S, Alkofahi A, Assaleh D, Al Shara A . Methicillin Resistant Staphylococcus aureus and public fomites: a review. Pathog Glob Health. 2020; 114(8):426-450. PMC: 7759291. DOI: 10.1080/20477724.2020.1824112. View